Financials Tempus AI, Inc.

Equities

Market Closed - Nasdaq Other stock markets 02:30:00 19/02/2026 am IST			After hours 06:26:35 am
56.16 ^USD	+6.85%		57.25	+1.94%

13/02	Tempus AI, Inc. Announces Collaboration with Median Technologies to Integrate AI-Powered Lung Cancer Screening into the Pixel Platform	CI
27/01	Tempus Says Study Shows AI-Driven Test More Accurately Predicts Immunotherapy Benefits	MT

Fiscal Period: December	2023	2024	2025	2026	2027
Net sales ¹	531.8	693.4	1,268	1,576	1,938
Change	-	30.38%	82.83%	24.3%	22.99%
EBITDA ¹	-	-104.7	0.5805	73.77	185
Change	-	-	100.55%	12,607.84%	150.76%
EBIT ¹	-	-142	-60.27	-19.21	116.9
Change	-	-	57.54%	68.12%	708.39%
Interest Paid ¹	-	-53.65	-67.54	-61.85	-60.32
Earnings before Tax (EBT) ¹	-	-701.3	-297.9	-217.7	-84.3
Change	-	-	57.52%	26.94%	61.27%
Net income ¹	-214.1	-746.3	-263.1	-223.2	-113.1
Change	-	-248.56%	64.74%	15.16%	49.34%
Announcement Date	20/05/24	24/02/25	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 Q3
Net sales ¹	166	180.9	200.7	255.7	314.6	334.2	362.9	344.4	381.3	407.4	443	415.9	472.8	502.2
Change	-	9.01%	10.92%	27.44%	23.03%	6.22%	8.58%	-5.1%	10.73%	6.82%	8.74%	-6.1%	13.66%	6.22%
EBITDA ¹	-31.19	-21.84	-7.752	-16.17	-5.58	1.476	20.91	-1.84	8.075	17.8	44.95	14.03	32.67	48.53
Change	-	29.96%	64.51%	-108.64%	65.5%	126.45%	1,316.96%	-108.8%	538.86%	120.43%	152.53%	-68.78%	132.78%	48.57%
EBIT ¹	-40.34	-31.28	-17.21	-25.78	-17.04	-8.662	-1.943	-22.46	-8.775	-1.05	25.25	-4.35	10.7	19.15
Change	-	22.46%	44.99%	-49.79%	33.91%	49.15%	77.57%	-1,056.03%	60.93%	88.03%	2,504.76%	-117.23%	345.98%	78.97%
Charge d'intérêts ¹	-11.58	-8.972	-13.36	-18	-21.58	-15.4	-14.74	-15.04	-15.04	-15.04	-15.04	-14.02	-14.02	-14.02
Earnings before Tax (EBT) ¹	-552.1	-74.11	-10.36	-112.3	-40.53	-81.22	-64.12	-68.57	-57.05	-52.42	-31.93	-49	-33.45	-25.88
Change	-	86.58%	86.03%	-984.72%	63.92%	-100.4%	21.06%	-6.94%	16.8%	8.12%	39.08%	-53.44%	31.73%	22.65%
Net income ¹	-564.4	-75.84	-53.54	-68.04	-42.84	-79.98	-64.93	-68.85	-57.32	-52.68	-32.12	-49.3	-33.78	-26.18
Change	-	86.56%	29.41%	-27.09%	37.03%	-86.69%	18.82%	-6.04%	16.75%	8.08%	39.04%	-53.5%	31.49%	22.5%
Announcement Date	06/08/24	04/11/24	24/02/25	06/05/25	08/08/25	04/11/25	-	-	-	-	-	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2023	2024	2025	2026	2027
Net Debt ¹	-	-13.7	613	554	417
Change	-	-	4,571.84%	-9.62%	-24.73%
Announcement Date	20/05/24	24/02/25	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2024	2025	2026	2027
CAPEX ¹	22.12	23.65	67.7	79
Change	-	6.91%	186.26%	16.69%
Free Cash Flow (FCF) ¹	-211.2	211.3	27.7	117.1
Change	-	200.06%	-86.89%	322.74%
Announcement Date	24/02/25	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2023	2024	2025	2026	2027
Profitability
EBITDA Margin (%)	-	-15.1%	0.05%	4.68%	9.54%
EBIT Margin (%)	-	-20.47%	-4.75%	-1.22%	6.03%
EBT Margin (%)	-	-101.14%	-23.5%	-13.81%	-4.35%
Net margin (%)	-40.26%	-107.63%	-20.76%	-14.17%	-5.84%
FCF margin (%)	-	-30.45%	16.67%	1.76%	6.04%
FCF / Net Income (%)	-	28.29%	-80.3%	-12.41%	-103.54%
Profitability
ROA	-	-25.37%	-6.82%	-1.61%	2.6%
ROE	-	-	-36.62%	-4.38%	17.84%
Financial Health
Leverage (Debt/EBITDA)	-	-	1,055.15x	7.5x	2.25x
Debt / Free cash flow	-	-	2.9x	19.98x	3.56x
Capital Intensity
CAPEX / Current Assets (%)	-	3.19%	1.87%	4.3%	4.08%
CAPEX / EBITDA (%)	-	-21.13%	4,074.14%	91.77%	42.71%
CAPEX / FCF (%)	-	-10.48%	11.19%	244.4%	67.46%
Items per share
Cash flow per share ¹	-	-1.577	-1.51	1.108	-
Change	-	-	4.28%	173.38%	-
Dividend per Share ¹	-	-	-	-	-
Change	-	-	-	-	-
Book Value Per Share ¹	-	0.3587	2.875	2.794	3.356
Change	-	-	701.47%	-2.82%	20.12%
EPS ¹	-	-6.23	-1.48	-1.265	-0.6653
Change	-	-	76.24%	14.56%	47.38%
Nbr of stocks (in thousands)	-	1,57,446	1,77,907	1,77,907	1,77,907
Announcement Date	-	24/02/25	-	-	-